A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen.
about
A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
A randomized, placebo-controll ...... in patients taking tamoxifen.
@en
type
label
A randomized, placebo-controll ...... in patients taking tamoxifen.
@en
prefLabel
A randomized, placebo-controll ...... in patients taking tamoxifen.
@en
P2093
P2860
P1476
A randomized, placebo-controll ...... in patients taking tamoxifen.
@en
P2093
Alison Stopeck
Betsy C Wertheim
Chuan Huang
Denise J Roe
Gertraud Maskarinec
H H Sherry Chow
Jean-Philippe Galons
Maria Altbach
Meghan B Strom
Patricia A Thompson
P2860
P2888
P304
P356
10.1007/S10549-017-4292-7
P407
P577
2017-05-30T00:00:00Z
P6179
1085727497